Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2

Journal of Hepatology

Volumn 62, Issue 3, 2015, Pages 657-663

  Zhou, You ^a   Llauradó, Gemma ^a,b   Orešič, Matej ^c   Hyötyläinen, Tuulia ^c   Orho Melander, Marju ^d   Yki Järvinen, Hannele ^a,e  

^a MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c STENO DIABETES CENTER   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Glucose production; Lipolysis; Magnetic resonance spectroscopy; Mass spectrometry

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPIDOME; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; TM6SF2 PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FINN (CITIZEN); GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GLUCONEOGENESIS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIVER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; AMINO ACID SUBSTITUTION; BLOOD; FINLAND; GENETIC ASSOCIATION; GENETICS; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOSE TISSUE; ADULT; AMINO ACID SUBSTITUTION; FEMALE; FINLAND; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84923064699     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.10.010     Document Type: Article

References (21)

1. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
2. H. Yki-Jarvinen Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Lancet Diabetes Endocrinol 2 2014 901 910
3. J. Kozlitina, E. Smagris, S. Stender, B.G. Nordestgaard, H.H. Zhou, and A. Tybjaerg-Hansen Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease Nat Genet 46 2014 352 356
4. J. Hyysalo, P. Gopalacharyulu, H. Bian, T. Hyotylainen, M. Leivonen, and N. Jaser Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity Diabetes 63 2014 312 322
5. H. Nygren, T. Seppanen-Laakso, S. Castillo, T. Hyotylainen, and M. Oresic Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues Methods Mol Biol 708 2011 247 257
6. T. Pluskal, S. Castillo, A. Villar-Briones, and M. Oresic MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data BMC Bioinformatics 11 2010 395
7. A. Kotronen, S. Vehkavaara, A. Seppala-Lindroos, R. Bergholm, and H. Yki-Jarvinen Effect of liver fat on insulin clearance Am J Physiol Endocrinol Metab 293 2007 E1709 E1715
8. L.S. Szczepaniak, P. Nurenberg, D. Leonard, J.D. Browning, J.S. Reingold, and S. Grundy Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
9. A. Kotronen, L. Juurinen, M. Tiikkainen, S. Vehkavaara, and H. Yki-Jarvinen Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes Gastroenterology 135 2008 122 130
10. A. Kotronen, M. Peltonen, A. Hakkarainen, K. Sevastianova, R. Bergholm, and L.M. Johansson Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors Gastroenterology 137 2009 865 872
11. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
12. J. Hyysalo, V.T. Mannisto, Y. Zhou, J. Arola, V. Karja, and M. Leivonen A population-based study on the prevalence of NASH using scores validated against liver histology J Hepatol 60 2014 839 846
13. Y. Hochberg, and Y. Benjamini More powerful procedures for multiple significance testing Stat Med 9 1990 811 818
14. O.L. Holmen, H. Zhang, Y. Fan, D.H. Hovelson, E.M. Schmidt, and W. Zhou Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk Nat Genet 46 2014 345 351
15. A. Kotronen, T. Seppanen-Laakso, J. Westerbacka, T. Kiviluoto, J. Arola, and A.L. Ruskeepaa Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver Diabetes 58 2009 203 208
16. J. Westerbacka, A. Kotronen, B.A. Fielding, J. Wahren, L. Hodson, and J. Perttila Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease Gastroenterology 139 2010 e1
17. A. Kotronen, V.R. Velagapudi, L. Yetukuri, J. Westerbacka, R. Bergholm, and K. Ekroos Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations Diabetologia 52 2009 684 690
18. J.Z. Li, Y. Huang, R. Karaman, P.T. Ivanova, H.A. Brown, and T. Roddy Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis J Clin Invest 122 2012 4130 4144
19. C. Pirazzi, M. Adiels, M.A. Burza, R.M. Mancina, M. Levin, and M. Stahlman Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro J Hepatol 57 2012 1276 1282
20. R.V. Farese Jr., R. Zechner, C.B. Newgard, and T.C. Walther The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance Cell Metab 15 2012 570 573
21. Y.L. Liu, H.L. Reeves, A.D. Burt, D. Tiniakos, S. McPherson, and J.B. Leathart TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309